Focused Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History

Focused Wealth Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9	Closed	–	–	678
2016 Q2	$0	Hold	9	–	–	﹤0.01%	692
2016 Q1	$0	Hold	9	–	–	﹤0.01%	683
2015 Q4	$0	Hold	9	–	–	﹤0.01%	691
2015 Q3	$0	Sell	9 -744	-99%	-$20.8K	﹤0.01%	689
2015 Q2	$21K	Hold	753	–	–	0.01%	305
2015 Q1	$21K	Hold	753	–	–	0.01%	311
2014 Q4	$19K	Hold	753	–	–	0.01%	318
2014 Q3	$17K	Hold	753	–	–	0.01%	342
2014 Q2	$16K	Hold	753	–	–	0.01%	348
2014 Q1	$16K	Buy	753 +26	+4%	+$579	0.01%	327
2013 Q4	$15K	Sell	727 -719	-50%	-$13.9K	0.01%	342
2013 Q3	$28K	Buy	+1,446	New	+$27.7K	0.03%	227

Other funds holding HQL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Focused Wealth Management's HQL Position: Q3 2016 in Review

Focused Wealth Management sold out of abrdn Life Sciences Investors (HQL) in Q3 2016, closing a stake of 9 shares.

Focused Wealth Management first reported a position in HQL in Q3 2013 and held it in 12 quarters. The position peaked at $28K in Q3 2013. 46 funds tracked by Wall St. Rank hold HQL as of Q3 2016.

Focused Wealth Management reported no remaining abrdn Life Sciences Investors position as of Q3 2016 after selling out during the quarter.
Focused Wealth Management sold 9 abrdn Life Sciences Investors shares in Q3 2016.
Focused Wealth Management first reported a position in abrdn Life Sciences Investors in Q3 2013 and held it in 12 quarters.
Focused Wealth Management's abrdn Life Sciences Investors position peaked at $28K in Q3 2013.
46 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2016.

Based on Focused Wealth Management's 13F filing for Q3 2016, filed 10 Nov 2016.